TDO2 Antikörper (N-Term)
Kurzübersicht für TDO2 Antikörper (N-Term) (ABIN631259)
Target
Alle TDO2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- TDO2 antibody was raised against the N terminal of TDO2
-
Aufreinigung
- Affinity purified
-
Immunogen
- TDO2 antibody was raised using the N terminal of TDO2 corresponding to a region with amino acids LFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSV
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TDO2 Blocking Peptide, (ABIN940326), is also available for use as a blocking control in assays to test for specificity of this TDO2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TDO2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TDO2 (Tryptophan 2,3-Dioxygenase (TDO2))
-
Andere Bezeichnung
- TDO2
-
Hintergrund
- Tryptophan 2,3-dioxygenase (EC 1.13.11.11) plays a role in catalyzing the first and rat-limiting step in the kynurenine pathway, the major pathway of tryptophan metabolism.
-
Molekulargewicht
- 48 kDa (MW of target protein)
Target
-